Sophie D. Fosså

Publications published in 1973 to 2009 or in press by Sophie Dorothea Fosså

745 publications found

Publications in press

1. Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Jacobsen AB, Thorsen L
   Interest and preferences for exercise counselling and programming among Norwegian cancer survivors
   Eur J Cancer Care (Engl) (in press)
   PubMed 20345456
2. Grov EK, Fosså SD, Dahl AA
   Insomnia in elderly cancer survivors-a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trøndelag County (HUNT-2) : Insomnia in elderly cancer survivors
   Support Care Cancer (in press)
   PubMed 20632038
3. Grov EK, Fosså SD, Dahl AA
   Short-term and long-term elderly cancer survivors: A population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle
   Eur J Oncol Nurs (in press)
   PubMed 20674499
4. Gudbergsson SB, Fosså SD, Dahl AA
   Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study
   Support Care Cancer (in press)
   PubMed 20135150
5. Kristiansen W, Haugen TB, Witczak O, Andersen JM, Fosså SD, Aschim EL
   CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility
   Int J Androl (in press)
   PubMed 20345875
6. Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S
   Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
   Acta Oncol (in press)
   PubMed 20586661
7. Zaikova O, Fosså SD, Kongsgaard U, Kvaløy S, Giercksky KE, Skjeldal S
   Pain after Palliative Radiotherapy for Spine Metastases
   Clin Oncol (R Coll Radiol) (in press)
   PubMed 20363110

Publications 2009

1. Aksnes LH, Bauer HC, Dahl AA, Fosså SD, Hjorth L, Jebsen N, Lernedal H, Hall KS (2009)
   Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group study
   Pediatr Blood Cancer, 53 (1), 84-9
   PubMed 19343771
2. Arriagada R, Averbeck D, Dahl AA, Darby S, Fosså S, Friberg S, Polgár C, de Vathaire F (2009)
   OECI Workshop on late side-effects of cancer treatments
   Eur J Cancer, 45 (3), 354-9
   PubMed 19081244
3. Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
   Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
   Prostate Cancer Prostatic Dis, 12 (3), 269-76
   PubMed 19290019
4. Bjerner J, Biernat D, Fosså SD, Bjøro T (2009)
   Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
   Scand J Clin Lab Invest, 69 (8), 873-9.e1-11
   PubMed 19929279
5. Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD (2009)
   Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
   J Natl Cancer Inst, 101 (24), 1682-95
   PubMed 19940282
6. Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA (2009)
   Nonsmoking: A Surrogate Factor in Primary Lung Cancer in Survivors of Cervical Adenocarcinoma? Reply
   J. Clin. Oncol., 27 (18), 3066-3067
7. Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA (2009)
   Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
   J Clin Oncol, 27 (6), 967-73
   PubMed 19114696
8. Cvancarova M, Samuelsen SO, Fossa SD (2009)
   Reproduction Rates After Cytotoxic Therapy Reply
   J. Clin. Oncol., 27 (27), E120
9. Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2009)
   Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
   J Clin Oncol, 27 (3), 334-43
   PubMed 19075285
10. Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA (2009)
    Long-term risk of receiving a total hip replacement in cancer patients
    Cancer Epidemiol, 33 (3-4), 235-41
    PubMed 19744907
11. Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
    [Incorrect about hormone treatment in prostatic cancer]
    Tidsskr Nor Laegeforen, 129 (5), 429
    PubMed 19247406
12. Fosså SD, Oldenburg J, Dahl AA (2009)
    Short- and long-term morbidity after treatment for testicular cancer
    BJU Int, 104 (9 Pt B), 1418-22
    PubMed 19840023
13. Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A, Scandinavian Prostate Cancer Group Study 7, Swedish Association for Urological Oncology 3 (2009)
    Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
    Lancet Oncol, 10 (4), 370-80
    PubMed 19286422
14. Grov EK, Fosså SD, Bremnes RM, Dahl O, Klepp O, Wist E, Dahl AA (2009)
    The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors
    Acta Oncol, 48 (6), 842-9
    PubMed 19412812
15. Grov EK, Fosså SD, Dahl AA (2009)
    Is somatic comorbidity associated with more somatic symptoms, mental distress, or unhealthy lifestyle in elderly cancer survivors?
    J Cancer Surviv, 3 (2), 109-16
    PubMed 19241174
16. Gudbergsson SB, Fosså SD, Lindbohm ML, Dahl AA (2009)
    Received and needed social support at the workplace in Norwegian and Finnish stage 1 breast cancer survivors: a study from the Nordic Study Group of Cancer and Work (NOCWO)
    Acta Oncol, 48 (1), 67-75
    PubMed 18759139
17. Haugnes HS, Aass N, Fosså SD, Dahl O, Brydøy M, Aasebø U, Wilsgaard T, Bremnes RM (2009)
    Pulmonary function in long-term survivors of testicular cancer
    J Clin Oncol, 27 (17), 2779-86
    PubMed 19414680
18. Kiserud CE, Fosså A, Bjøro T, Holte H, Cvancarova M, Fosså SD (2009)
    Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
    Br J Cancer, 100 (3), 455-63
    PubMed 19156143
19. Kiserud CE, Schover LR, Dahl AA, Fosså A, Bjøro T, Loge JH, Holte H, Yuan Y, Fosså SD (2009)
    Do male lymphoma survivors have impaired sexual function?
    J Clin Oncol, 27 (35), 6019-26
    PubMed 19858388
20. Kraggerud SM, Oldenburg J, Alnaes GI, Berg M, Kristensen VN, Fossa SD, Lothe RA (2009)
    Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology
    Pharmacogenet Genomics, 19 (10), 751-9
    PubMed 19741569
21. Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ (2009)
    Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
    BJU Int, 103 (12), 1647-54
    PubMed 19154461
22. Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale AL, Dumeaux V (2009)
    Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
    Pharmacogenomics J, 9 (5), 333-40
    PubMed 19546881
23. Liavaag AH, Dørum A, Fosså SD, Tropé C, Dahl AA (2009)
    Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors
    BMC Cancer, 9, 2
    PubMed 19121203
24. Mai PL, Chen BE, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, Heimdal K, Fosså SD, Nathanson KL, Korde L, Easton DF, Dudakia D, Huddart R, Stratton MR, Bishop DT, Rapley EA, Greene MH (2009)
    Younger age-at-diagnosis for familial malignant testicular germ cell tumor
    Fam Cancer, 8 (4), 451-6
    PubMed 19609727
25. Michelsen TM, Dørum A, Tropé CG, Fosså SD, Dahl AA (2009)
    Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer
    Int J Gynecol Cancer, 19 (6), 1029-36
    PubMed 19820364
26. Nesvold IL, Fosså SD, Naume B, Dahl AA (2009)
    Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors
    Breast Cancer Res Treat, 117 (2), 281-8
    PubMed 19112616
27. Oldenburg J, Fosså SD (2009)
    [Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders]
    Urologe A, 48 (4), 372-6
    PubMed 19234684
28. Oldenburg J, Fosså SD (2009)
    Late relapse of nonseminomatous germ cell tumours
    BJU Int, 104 (9 Pt B), 1413-7
    PubMed 19840022
29. Oldenburg J, Fosså SD (2009)
    Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations
    Acta Oncol, 48 (6), 804-6
    PubMed 19484592
30. Oldenburg J, Wahlqvist R, Fosså SD (2009)
    Late relapse of germ cell tumors
    World J Urol, 27 (4), 493-500
    PubMed 19373473
31. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
    Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
    Brain Behav Immun, 23 (6), 868-74
    PubMed 19362138
32. Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD (2009)
    Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
    Int J Radiat Oncol Biol Phys, 75 (3), 764-70
    PubMed 19286332
33. Schröder FH, Kurth KH, Fossa SD, Hoekstra W, Karthaus PP, De Prijck L, Collette L (2009)
    Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial)
    Eur Urol, 55 (1), 14-22
    PubMed 18823693
34. Skaali T, Fosså SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, Klepp O, Oldenburg J, Wist E, Dahl AA (2009)
    Fear of recurrence in long-term testicular cancer survivors
    Psychooncology, 18 (6), 580-8
    PubMed 18855944
35. Stensheim H, Miller B, van Dijk T, Fossa SD (2009)
    Cancer During Pregnancy: The Time Has Come for a Prospective Program Reply
    J. Clin. Oncol., 27 (13), 2299
36. Stensheim H, Moller B, van Dijk T, Fossa SD (2009)
    Cutaneous Melanoma During Pregnancy: Is the Controversy Over? Reply
    J. Clin. Oncol., 27 (19), E13-E14
37. Stensheim H, Møller B, van Dijk T, Fosså SD (2009)
    Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study
    J Clin Oncol, 27 (1), 45-51
    PubMed 19029418
38. Vistad I, Kristensen GB, Fosså SD, Dahl AA, Mørkrid L (2009)
    Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy
    Int J Radiat Oncol Biol Phys, 73 (4), 1141-7
    PubMed 18760883
39. Vågane R, Danielsen T, Fosså SD, Løkkevik E, Olsen DR (2009)
    Late regional density changes of the lung after radiotherapy for breast cancer
    Radiother Oncol, 90 (1), 148-52
    PubMed 18262670
40. Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, Kjekshus J, Fosså A (2009)
    Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
    Br J Cancer, 101 (4), 575-81
    PubMed 19623176
41. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fossa SD (2009)
    Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial (vol 373, pg 301, 2009)
    Lancet, 373 (9670), 1174
42. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD, Scandinavian Prostate Cancer Group Study 7, Swedish Association for Urological Oncology 3 (2009)
    Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
    Lancet, 373 (9660), 301-8
    PubMed 19091394
43. Zaikova O, Giercksky KE, Fosså SD, Kvaløy S, Johannesen TB, Skjeldal S (2009)
    A population-based study of spinal metastatic disease in South-East Norway
    Clin Oncol (R Coll Radiol), 21 (10), 753-9
    PubMed 19850454

Publications 2008

1. Berg Gudbergsson S, Fosså SD, Dahl AA (2008)
   Is cancer survivorship associated with reduced work engagement? A NOCWO Study
   J Cancer Surviv, 2 (3), 159-68
   PubMed 18654861
2. Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
   Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
   Prostate, 68 (15), 1607-14
   PubMed 18655095
3. Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
   Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
   Acta Oncol, 47 (8), 1475-82
   PubMed 18607853
4. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB (2008)
   Re: Second cancers among 104760 survivors of cervical cancer: Evaluation of long-term risk - Reply
   J. Natl. Cancer Inst., 100 (8), 600-601
5. Di Lorenzo G, Figg WD, Fossa SD, Mirone V, Autorino R, Longo N, Imbimbo C, Perdonà S, Giordano A, Giuliano M, Labianca R, De Placido S (2008)
   Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study
   Eur Urol, 54 (5), 1089-94
   PubMed 18276061
6. Fizazi K, Oldenburg J, Dunant A, Chen I, Salvioni R, Hartmann JT, De Santis M, Daugaard G, Flechon A, de Giorgi U, Tjulandin S, Schmoll HJ, Bouzy J, Fossa SD, Fromont G (2008)
   Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study
   Ann Oncol, 19 (2), 259-64
   PubMed 18042838
7. Fosså SD (2008)
   A randomized phase II trial comparing weekly taxotere plus prednisolone versus prednisolone alone in androgen-independent prostate cancer
   Front Radiat Ther Oncol, 41, 108-16
   PubMed 18544992
8. Fosså SD, Dahl AA (2008)
   Fertility and sexuality in young cancer survivors who have adult-onset malignancies
   Hematol Oncol Clin North Am, 22 (2), 291-303, vii
   PubMed 18395151
9. Fosså SD, Dahl AA, Smeland S, Thorsen L, Loge JH (2008)
   [Rehabilitation after cancer]
   Tidsskr Nor Laegeforen, 128 (22), 2615-6
   PubMed 19023358
10. Fosså SD, Kvaløy J, Kvaløy S, Loge JH, Dahl AA (2008)
    [Courses for cancer patients--15 years' experience at The Montebello Centre in Norway]
    Tidsskr Nor Laegeforen, 128 (22), 2554-7
    PubMed 19023349
11. Fosså SD, Loge JH, Dahl AA (2008)
    Long-term survivorship after cancer: how far have we come?
    Ann Oncol, 19 Suppl 5, v25-9
    PubMed 18611895
12. Fosså SD, Vassilopoulou-Sellin R, Dahl AA (2008)
    Long term physical sequelae after adult-onset cancer
    J Cancer Surviv, 2 (1), 3-11
    PubMed 18648982
13. Gudbergsson SB, Fosså SD, Dahl AA, NOCWO (2008)
    A study of work changes due to cancer in tumor-free primary-treated cancer patients. A NOCWO study
    Support Care Cancer, 16 (10), 1163-71
    PubMed 18256856
14. Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2008)
    Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
    J Cancer Surviv, 2 (3), 128-37
    PubMed 18792787
15. Hernes E, Johansson LA, Fosså SD, Pedersen AG, Glattre E (2008)
    High prostate cancer mortality in Norway evaluated by automated classification of medical entities
    Eur J Cancer Prev, 17 (4), 331-5
    PubMed 18562957
16. Howard R, Gilbert E, Lynch CF, Hall P, Storm H, Holowaty E, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Allan JM, Travis LB (2008)
    Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients
    Ann Epidemiol, 18 (5), 416-21
    PubMed 18433667
17. Ikdahl T, Josefsen D, Jakobsen E, Delabie J, Fosså SD (2008)
    Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature
    Acta Oncol, 47 (3), 466-9
    PubMed 18348004
18. Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD (2008)
    [Gonadal function after cancer treatment in adult men]
    Tidsskr Nor Laegeforen, 128 (4), 461-5
    PubMed 18274582
19. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PHM, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fossa SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GON, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H (2008)
    European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European germ cell cancer consensus group (EGCCCG): Part 1 (vol 53, pg 478, 2008)
    Eur. Urol., 54 (2), 480
20. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Stahl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PHM, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fossa SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GON, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H (2008)
    European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European germ cell cancer consensus group (EGCCCG): Part II (vol 53, pg 497, 2008)
    Eur. Urol., 54 (2), 480
21. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Paz-Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H (2008)
    European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
    Eur Urol, 53 (3), 497-513
    PubMed 18191015
22. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H (2008)
    European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
    Eur Urol, 53 (3), 478-96
    PubMed 18191324
23. Liavaag AH, Dørum A, Bjøro T, Oksefjell H, Fosså SD, Tropé C, Dahl AA (2008)
    A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach
    Gynecol Oncol, 108 (2), 348-54
    PubMed 17996925
24. Linger R, Dudakia D, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Stoppa-Lyonnet D, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Daly PA, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Einhorn L, McMaster M, Korde L, Greene MH, Nathanson KL, Cortessis V, Easton DF, Bishop DT, Stratton MR, Rapley EA (2008)
    Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors
    Genes Chromosomes Cancer, 47 (3), 247-52
    PubMed 18069663
25. Magelssen H, Melve KK, Skjaerven R, Fosså SD (2008)
    Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood
    Hum Reprod, 23 (1), 178-86
    PubMed 18024486
26. Nesvold IL, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD (2008)
    Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy
    Acta Oncol, 47 (5), 835-42
    PubMed 18568481
27. Oldenburg J, Fosså SD, Ikdahl T (2008)
    Genetic variants associated with cisplatin-induced ototoxicity
    Pharmacogenomics, 9 (10), 1521-30
    PubMed 18855538
28. Oldenburg J, Lehne G, Fosså SD (2008)
    [Testicular cancer]
    Tidsskr Nor Laegeforen, 128 (4), 457-60
    PubMed 18274581
29. Orre IJ, Fosså SD, Murison R, Bremnes R, Dahl O, Klepp O, Loge JH, Wist E, Dahl AA (2008)
    Chronic cancer-related fatigue in long-term survivors of testicular cancer
    J Psychosom Res, 64 (4), 363-71
    PubMed 18374735
30. Steinsvik EA, Fosså SD, Lilleby W, Eilertsen K (2008)
    Fertility issues in patients with prostate cancer
    BJU Int, 102 (7), 793-5
    PubMed 18489529
31. Thorsen L, Courneya KS, Stevinson C, Fosså SD (2008)
    A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants
    Support Care Cancer, 16 (9), 987-97
    PubMed 18274783
32. van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK (2008)
    An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer
    Eur J Cancer, 44 (16), 2418-24
    PubMed 18774706
33. Vistad I, Cvancarova M, Fosså SD, Kristensen GB (2008)
    Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
    Int J Radiat Oncol Biol Phys, 71 (5), 1335-42
    PubMed 18355976
34. Vågane R, Bruland ØS, Fosså SD, Olsen DR (2008)
    Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation
    Acta Oncol, 47 (2), 248-54
    PubMed 18210300

Publications 2007

1. Aksnes LH, Hall KS, Jebsen N, Fosså SD, Dahl AA (2007)
   Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
   Support Care Cancer, 15 (9), 1087-96
   PubMed 17347843
2. Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
   Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
   Int J Cancer, 120 (8), 1603-9
   PubMed 17230512
3. Berg A, Lilleby W, Bruland OS, Fosså SD (2007)
   10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
   Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
   PubMed 17703896
4. Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fosså SD, Travis LB (2007)
   Risk of second non-hematological malignancies among 376,825 breast cancer survivors
   Breast Cancer Res Treat, 106 (3), 439-51
   PubMed 17277968
5. Brydøy M, Fosså SD, Dahl O, Bjøro T (2007)
   Gonadal dysfunction and fertility problems in cancer survivors
   Acta Oncol, 46 (4), 480-9
   PubMed 17497315
6. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB (2007)
   Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
   J Natl Cancer Inst, 99 (21), 1634-43
   PubMed 17971527
7. Dahl AA, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2007)
   Is the sexual function compromised in long-term testicular cancer survivors?
   Eur Urol, 52 (5), 1438-47
   PubMed 17350159
8. Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein B, Helland A, Børresen-Dale AL, Fosså SD (2007)
   Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy
   Int J Radiat Oncol Biol Phys, 67 (4), 1163-71
   PubMed 17336217
9. Edvardsen H, Tefre T, Jansen L, Vu P, Haffty BG, Fosså SD, Kristensen VN, Børresen-Dale AL (2007)
   Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
   Radiat Oncol, 2, 25
   PubMed 17623063
10. Fosså SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, Storm H, Hall P, Holowaty E, Andersen A, Joensuu H, Andersson M, Kaijser M, Gospodarowicz M, Cohen R, Pukkala E, Travis LB (2007)
    Noncancer causes of death in survivors of testicular cancer
    J Natl Cancer Inst, 99 (7), 533-44
    PubMed 17405998
11. Fosså SD, Hess SL, Dahl AA, Hjermstad MJ, Veenstra M (2007)
    Stability of health-related quality of life in the Norwegian general population and impact of chronic morbidity in individuals with and without a cancer diagnosis
    Acta Oncol, 46 (4), 452-61
    PubMed 17497312
12. Fosså SD, Jacobsen AB, Ginman C, Jacobsen IN, Overn S, Iversen JR, Urnes T, Dahl AA, Veenstra M, Sandstad B (2007)
    Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study
    Eur Urol, 52 (6), 1691-8
    PubMed 17306441
13. Gudbergsson SB, Fosså SD, Ganz PA, Zebrack BJ, Dahl AA (2007)
    The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study
    Support Care Cancer, 15 (11), 1309-18
    PubMed 17450387
14. Gudbergsson SB, Fosså SD, Sanne B, Dahl AA (2007)
    A controlled study of job strain in primary-treated cancer patients without metastases
    Acta Oncol, 46 (4), 534-44
    PubMed 17497321
15. Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Svartberg J, Wilsgaard T, Bremnes RM (2007)
    Components of the metabolic syndrome in long-term survivors of testicular cancer
    Ann Oncol, 18 (2), 241-8
    PubMed 17060482
16. Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB (2007)
    Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
    J Clin Oncol, 25 (12), 1489-97
    PubMed 17372278
17. Howard RA, Gilbert ES, Chen BE, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Travis LB (2007)
    Leukemia following breast cancer: an international population-based study of 376,825 women
    Breast Cancer Res Treat, 105 (3), 359-68
    PubMed 17221155
18. Kiserud CE, Fosså A, Holte H, Fosså SD (2007)
    Post-treatment parenthood in Hodgkin's lymphoma survivors
    Br J Cancer, 96 (9), 1442-9
    PubMed 17406362
19. Liavaag AH, Dørum A, Fosså SD, Tropé C, Dahl AA (2007)
    Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
    J Clin Oncol, 25 (15), 2049-56
    PubMed 17513809
20. Nord C, Ganz PA, Aziz N, Fosså SD (2007)
    Follow-up of long-term cancer survivors in the Nordic countries
    Acta Oncol, 46 (4), 433-40
    PubMed 17497309
21. Oldenburg J, Kraggerud SM, Brydøy M, Cvancarova M, Lothe RA, Fossa SD (2007)
    Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study
    J Transl Med, 5, 70
    PubMed 18162130
22. Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD (2007)
    Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors
    J Clin Oncol, 25 (6), 708-14
    PubMed 17228018
23. Oldervoll LM, Loge JH, Kaasa S, Lydersen S, Hjermstad MJ, Thorsen L, Holte H, Jacobsen AB, Fosså SD (2007)
    Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study
    BMC Cancer, 7, 210
    PubMed 17997822
24. Røtterud R, Fosså SD, Nesland JM (2007)
    Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
    Histol Histopathol, 22 (4), 349-63
    PubMed 17290345
25. Schairer C, Hisada M, Chen BE, Brown LM, Howard R, Fosså SD, Gail M, Travis LB (2007)
    Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers
    J Natl Cancer Inst, 99 (16), 1248-56
    PubMed 17686826
26. Schlichting E, Nielsen HB, Fosså SD, Aasland OG (2007)
    [Women's academic careers in medicine]
    Tidsskr Nor Laegeforen, 127 (16), 2109-12
    PubMed 17717577
27. Thorsen L, Dahl AA, Skovlund E, Hornslien K, Fosså SD (2007)
    Effectiveness after 1 year of a short-term physical activity intervention on cardiorespiratory fitness in cancer patients
    J Clin Oncol, 25 (10), 1301-2
    PubMed 17401029
28. Vergouwe Y, Steyerberg EW, Foster RS, Sleijfer DT, Fosså SD, Gerl A, de Wit R, Roberts JT, Habbema JD (2007)
    Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients
    Eur Urol, 51 (2), 424-32
    PubMed 16911854
29. Vistad I, Fosså SD, Kristensen GB, Dahl AA (2007)
    Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy
    BJOG, 114 (9), 1150-8
    PubMed 17655733
30. Vistad I, Fosså SD, Kristensen GB, Mykletun A, Dahl AA (2007)
    The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample
    J Womens Health (Larchmt), 16 (1), 139-48
    PubMed 17324105
31. Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
    Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
    J Cancer Surviv, 1 (1), 8-16
    PubMed 18648940

Publications 2006

1. Christophersen AO, Lie AK, Fosså SD (2006)
   Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma
   Acta Oncol, 45 (2), 226-8
   PubMed 16546876
2. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Forman D, Oliver T, Einhorn L, McMaster M, Kramer J, Greene MH, Weber BL, Nathanson KL, Cortessis V, Easton DF, Bishop DT, Stratton MR, Rapley EA (2006)
   Genome-wide linkage screen for testicular germ cell tumour susceptibility loci
   Hum Mol Genet, 15 (3), 443-51
   PubMed 16407372
3. Fosså SD, Johannesen TB, Lehne G (2006)
   Long-term outcome after adult-onset cancer
   Ann Oncol, 17 Suppl 10, x293-8
   PubMed 17018741
4. Grov EK, Dahl AA, Fosså SD, Wahl AK, Moum T (2006)
   Global quality of life in primary caregivers of patients with cancer in palliative phase staying at home
   Support Care Cancer, 14 (9), 943-51
   PubMed 16523266
5. Grov EK, Fosså SD, Sørebø O, Dahl AA (2006)
   Primary caregivers of cancer patients in the palliative phase: a path analysis of variables influencing their burden
   Soc Sci Med, 63 (9), 2429-39
   PubMed 16887247
6. Grov EK, Fosså SD, Tønnessen A, Dahl AA (2006)
   The caregiver reaction assessment: psychometrics, and temporal stability in primary caregivers of Norwegian cancer patients in late palliative phase
   Psychooncology, 15 (6), 517-27
   PubMed 16189843
7. Gudbergsson SB, Fosså SD, Borgeraas E, Dahl AA (2006)
   A comparative study of living conditions in cancer patients who have returned to work after curative treatment
   Support Care Cancer, 14 (10), 1020-9
   PubMed 16572315
8. Haukvik UK, Dieset I, Bjøro T, Holte H, Fosså SD (2006)
   Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
   Ann Oncol, 17 (9), 1428-33
   PubMed 16831852
9. Hjermstad MJ, Oldervoll L, Fosså SD, Holte H, Jacobsen AB, Loge JH (2006)
   Quality of life in long-term Hodgkin's disease survivors with chronic fatigue
   Eur J Cancer, 42 (3), 327-33
   PubMed 16377179
10. Jacobsen KD, Fosså SD, Aamdal S (2006)
    [Malignant melanoma--diagnosis and treatment]
    Tidsskr Nor Laegeforen, 126 (23), 3094-7
    PubMed 17160112
11. Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD (2006)
    [Curative treatment of prostatic cancer in Norway in 1998 and 2001]
    Tidsskr Nor Laegeforen, 126 (7), 912-6
    PubMed 16554883
12. Lilleby W, Hernes E, Waehre H, Raabe N, Fosså SD (2006)
    [Treatment of hormone-resistant prostate cancer]
    Tidsskr Nor Laegeforen, 126 (21), 2798-801
    PubMed 17086220
13. Magelssen H, Brydøy M, Fosså SD (2006)
    The effects of cancer and cancer treatments on male reproductive function
    Nat Clin Pract Urol, 3 (6), 312-22
    PubMed 16763643
14. Mykletun A, Dahl AA, O'Leary MP, Fosså SD (2006)
    Assessment of male sexual function by the Brief Sexual Function Inventory
    BJU Int, 97 (2), 316-23
    PubMed 16430637
15. Oldenburg J, Alfsen GC, Waehre H, Fosså SD (2006)
    Late recurrences of germ cell malignancies: a population-based experience over three decades
    Br J Cancer, 94 (6), 820-7
    PubMed 16508636
16. Oldenburg J, Fosså SD, Dahl AA (2006)
    Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors
    Qual Life Res, 15 (5), 791-800
    PubMed 16721639
17. Oldenburg J, Martin JM, Fosså SD (2006)
    Late relapses of germ cell malignancies: incidence, management, and prognosis
    J Clin Oncol, 24 (35), 5503-11
    PubMed 17158535
18. Schairer C, Brown LM, Chen BE, Howard R, Lynch CF, Hall P, Storm H, Pukkala E, Anderson A, Kaijser M, Andersson M, Joensuu H, Fosså SD, Ganz PA, Travis LB (2006)
    Suicide after breast cancer: an international population-based study of 723,810 women
    J Natl Cancer Inst, 98 (19), 1416-9
    PubMed 17018788
19. Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, Storm H, Andersen A, Pukkala E, Holowaty E, Kaijser M, Andersson M, Joensuu H, Fosså SD, Allan JM, Travis LB (2006)
    Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
    J Natl Cancer Inst, 98 (3), 215-8
    PubMed 16449681
20. Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C, Collette L, EORTC Genito-Urinary Cancer Group (2006)
    Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
    Eur J Cancer, 42 (1), 50-4
    PubMed 16330205
21. Sørlie T, Rosenvinge JH, Bremnes R, Balteskard L, Dahl AA, Klepp O, Fosså SD (2006)
    Management satisfaction in survivors of testicular cancer
    Anticancer Res, 26 (2B), 1463-9
    PubMed 16619559
22. Thorsen L, Nystad W, Stigum H, Hjermstad M, Oldervoll L, Martinsen EW, Hornslien K, Strømme SB, Dahl AA, Fosså SD (2006)
    Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy
    J Sports Med Phys Fitness, 46 (1), 122-7
    PubMed 16596110
23. Vistad I, Fosså SD, Dahl AA (2006)
    A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer
    Gynecol Oncol, 102 (3), 563-72
    PubMed 16716379
24. Yri OE, Bjoro T, Fossa SD (2006)
    Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer
    Eur Urol, 49 (1), 54-8; discussion 58
    PubMed 16314038

Publications 2005

1. Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O (2005)
   Paternity following treatment for testicular cancer
   J Natl Cancer Inst, 97 (21), 1580-8
   PubMed 16264178
2. Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2005)
   Study of anxiety disorder and depression in long-term survivors of testicular cancer
   J Clin Oncol, 23 (10), 2389-95
   PubMed 15800331
3. Dahl AA, Mykletun A, Fosså SD (2005)
   Quality of life in survivors of testicular cancer
   Urol Oncol, 23 (3), 193-200
   PubMed 15907721
4. Dearnaley DP, Fossa SD, Kaye SB, Cullen MH, Harland SJ, Sokal MP, Graham JD, Roberts JT, Mead GM, Williams MV, Cook PA, Stenning SP, MRC Testicular Tumour Working Party (2005)
   Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
   Br J Cancer, 92 (12), 2107-13
   PubMed 15928672
5. Fosså SD (2005)
   [Are all LH-RH analogues equally effective in prostate cancer?]
   Tidsskr Nor Laegeforen, 125 (18), 2493-5
   PubMed 16186869
6. Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB (2005)
   Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men
   J Natl Cancer Inst, 97 (14), 1056-66
   PubMed 16030303
7. Fosså SD, Holte H, Holmen MM, Bjøro T, Langmark F, Hess SL, Kvaløy S (2005)
   [Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
   Tidsskr Nor Laegeforen, 125 (1), 41-4
   PubMed 15643464
8. Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R (2005)
   Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
   J Natl Cancer Inst Monogr (34), 77-82
   PubMed 15784830
9. Fosså SD, Paluchowska B, Horwich A, Kaiser G, de Mulder PH, Koriakine O, van Oosterom AT, de Prijck L, Collette L, de Wit R, EORTC GU Group (2005)
   Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
   Br J Cancer, 93 (11), 1209-14
   PubMed 16251877
10. Fosså SD, Wahlqvist R (2005)
    [Radical treatment of prostatic cancer in Norway]
    Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
    PubMed 16244698
11. Grov EK, Dahl AA, Moum T, Fosså SD (2005)
    Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase
    Ann Oncol, 16 (7), 1185-91
    PubMed 15849218
12. Hernes E, Harvei S, Glattre E, Gjertsen F, Fosså SD (2005)
    High prostate cancer mortality in Norway: influence of Cancer Registry information?
    APMIS, 113 (7-8), 542-9
    PubMed 16086825
13. Hjermstad MJ, Fosså SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH (2005)
    Fatigue in long-term Hodgkin's Disease survivors: a follow-up study
    J Clin Oncol, 23 (27), 6587-95
    PubMed 16170166
14. Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP (2005)
    Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)
    J Clin Oncol, 23 (6), 1200-8
    PubMed 15718317
15. Josefsen D, Fosså S (2005)
    The management strategies for stage I seminoma
    Clin Oncol (R Coll Radiol), 17 (7), 539-42
    PubMed 16238141
16. Lilleby W, Fosså SD (2005)
    Chemotherapy in metastatic renal cell cancer
    World J Urol, 23 (3), 175-9
    PubMed 15726382
17. Lilleby W, Sudbø J, Fosså SD (2005)
    [Biology and treatment options during the development of prostate cancer]
    Tidsskr Nor Laegeforen, 125 (5), 571-4
    PubMed 15776028
18. Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD (2005)
    Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
    Eur Urol, 48 (5), 779-85
    PubMed 15963629
19. Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2005)
    Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer
    J Clin Oncol, 23 (13), 3061-8
    PubMed 15860864
20. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Oosterhuis JW, Gillis AJ, Looijenga LH, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Rudd M, Huddart R, Crockford GP, Forman D, Oliver DT, Einhorn L, Weber BL, Kramer J, McMaster M, Greene MH, Pike M, Cortessis V, Chen C, Schwartz SM, Bishop DT, Easton DF, Stratton MR, Rapley EA (2005)
    The Y deletion gr/gr and susceptibility to testicular germ cell tumor
    Am J Hum Genet, 77 (6), 1034-43
    PubMed 16380914
21. Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005)
    First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
    Clin Cancer Res, 11 (12), 4451-9
    PubMed 15958630
22. Nord C, Mykletun A, Thorsen L, Bjøro T, Fosså SD (2005)
    Self-reported health and use of health care services in long-term cancer survivors
    Int J Cancer, 114 (2), 307-16
    PubMed 15543613
23. Røtterud R, Nesland JM, Berner A, Fosså SD (2005)
    Expression of the epidermal growth factor receptor family in normal and malignant urothelium
    BJU Int, 95 (9), 1344-50
    PubMed 15892828
24. Sagstuen H, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2005)
    Blood pressure and body mass index in long-term survivors of testicular cancer
    J Clin Oncol, 23 (22), 4980-90
    PubMed 16051950
25. Skarstein J, Bjelland I, Dahl AA, Laading J, Fosså SD (2005)
    Is there an association between haemoglobin, depression, and anxiety in cancer patients?
    J Psychosom Res, 58 (6), 477-83
    PubMed 16125514
26. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA (2005)
    Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
    Cancer Res, 65 (13), 5588-98
    PubMed 15994931
27. Stenning SP, Jones WG, Fossa SD (2005)
    Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: A report on Medical Research Council Trial TE 18, European Organisation for Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) - Reply
    J. Clin. Oncol., 23 (27), 6806-6807
28. Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2005)
    The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample
    Support Care Cancer, 13 (8), 637-46
    PubMed 15756585
29. Thorsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD (2005)
    Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy
    J Clin Oncol, 23 (10), 2378-88
    PubMed 15800330
30. Torlakovic E, Lilleby W, Berner A, Torlakovic G, Chibbar R, Furre T, Fosså SD (2005)
    Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma
    Int J Cancer, 117 (3), 381-6
    PubMed 15900599
31. Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Dores GM, Gilbert ES (2005)
    Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
    J Natl Cancer Inst, 97 (18), 1354-65
    PubMed 16174857
32. Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ (2005)
    Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
    J Clin Oncol, 23 (18), 4172-8
    PubMed 15961764
33. Aass N, Fosså SD (2005)
    Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression
    Radiother Oncol, 74 (3), 259-65
    PubMed 15763306

Publications 2004

1. Collette L, van Andel G, Bottomley A, Oosterhof GO, Albrecht W, de Reijke TM, Fossà SD (2004)
   Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group
   J Clin Oncol, 22 (19), 3877-85
   PubMed 15459209
2. Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB (2004)
   NY-ESO-1 protein expression and humoral immune responses in prostate cancer
   Prostate, 59 (4), 440-7
   PubMed 15065093
3. Fosså SD (2004)
   Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer
   Acta Oncol, 43 (2), 134-41
   PubMed 15163161
4. Fosså SD, Magelssen H (2004)
   Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer
   Ann Oncol, 15 Suppl 4, iv259-65
   PubMed 15477318
5. Fosså SD, Mickisch GH, De Mulder PH, Horenblas S, van Oosterom AT, van Poppel H, Fey M, Croles JJ, de Prijck L, Van Glabbeke M (2004)
   Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma
   Cancer, 101 (3), 533-40
   PubMed 15274066
6. Fosså SD, Aass N, Harvei S, Tretli S (2004)
   Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
   Br J Cancer, 90 (3), 607-12
   PubMed 14760372
7. Hernes E, Fosså SD, Berner A, Otnes B, Nesland JM (2004)
   Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
   Br J Cancer, 90 (2), 449-54
   PubMed 14735192
8. Norderhaug IN, Sandberg S, Fossa SD, Forland F, Malde K, Kvinnsland S, Traaholt I, Rossine BK, Forde OH (2004)
   Health technology assessment and implications for clinical practice: the case of prostate cancer screening. (vol 63, pg 331, 2003)
   Scand. J. Clin. Lab. Invest., 64 (8), 757
9. Norderhaug IN, Wisløff T, Fosså S, Sandberg S, Malde K, Forland F, Førde OH (2004)
   [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians]
   Tidsskr Nor Laegeforen, 124 (22), 2893-5
   PubMed 15550959
10. Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Heidenreich A, Geczi L, Bodrogi I, Olah E, Ormiston WJ, Daly PA, Looijenga LH, Guilford P, Aass N, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Einhorn L, Weber BL, McMaster M, Greene MH, Bishop DT, Easton D, Stratton MR (2004)
    Somatic mutations of KIT in familial testicular germ cell tumours
    Br J Cancer, 90 (12), 2397-401
    PubMed 15150569
11. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M, Derigs HG, Dieckmann KP, Flasshove M, Garcia del Muro X, Gerl A, Germa-Lluch JR, Hartmann M, Heidenreich A, Hoeltl W, Joffe J, Jones W, Kaiser G, Klepp O, Kliesch S, Kisbenedek L, Koehrmann KU, Kuczyk M, Laguna MP, Leiva O, Loy V, Mason MD, Mead GM, Mueller RP, Nicolai N, Oosterhof GO, Pottek T, Rick O, Schmidberger H, Sedlmayer F, Siegert W, Studer U, Tjulandin S, von der Maase H, Walz P, Weinknecht S, Weissbach L, Winter E, Wittekind C, European Germ Cell Cancer Consensus Group (2004)
    European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
    Ann Oncol, 15 (9), 1377-99
    PubMed 15319245
12. Schröder FH, Kurth KH, Fosså SD, Hoekstra W, Karthaus PP, Debois M, Collette L, Members of the European Organisation for the Research and Treatment of Cancer Genito-urinary Group (2004)
    Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study
    J Urol, 172 (3), 923-7
    PubMed 15310999
13. Stensvold E, Aass N, Gladhaug I, Stenwig AE, Claussen OP, Fosså SD (2004)
    Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer
    Eur J Surg Oncol, 30 (3), 352-5
    PubMed 15028321

Publications 2003

1. Bokemeyer C, Hartmann JT, Fossa SD, Droz JP, Schmol HJ, Horwich A, Gerl A, Beyer J, Pont J, Kanz L, Nichols CR, Einhorn L (2003)
   Extragonadal germ cell tumors: relation to testicular neoplasia and management options
   APMIS, 111 (1), 49-59; discussion 59-63
   PubMed 12752235
2. Christian JA, Huddart RA, Norman A, Mason M, Fossa S, Aass N, Nicholl EJ, Dearnaley DP, Horwich A (2003)
   Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
   J Clin Oncol, 21 (5), 871-7
   PubMed 12610187
3. Fosså SD, Dahl AA, Loge JH (2003)
   Fatigue, anxiety, and depression in long-term survivors of testicular cancer
   J Clin Oncol, 21 (7), 1249-54
   PubMed 12663711
4. Fosså SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L, European Organization for Research and Treatment of Cancer Genitourinary Group 30941, Medical Research Council Testicular Cancer Study Group TE20 (2003)
   Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
   J Clin Oncol, 21 (6), 1107-18
   PubMed 12637478
5. Fosså SD, Lilleby W, Waehre H, Berner A, Torlakovic G, Paus E, Olsen DR (2003)
   Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy
   Int J Radiat Oncol Biol Phys, 57 (1), 33-41
   PubMed 12909213
6. Fosså SD, Aass N, Heilo A, Daugaard G, E Skakkebaek N, Stenwig AE, Nesland JM, Looijenga LH, Oosterhuis JW (2003)
   Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
   Ann Oncol, 14 (9), 1412-8
   PubMed 12954581
7. Guren MG, Dueland S, Skovlund E, Fosså SD, Poulsen JP, Tveit KM (2003)
   Quality of life during radiotherapy for rectal cancer
   Eur J Cancer, 39 (5), 587-94
   PubMed 12628837
8. Hernes E, Fosså SD, Skovlund E (2003)
   Androgen-independent prostate cancer--the clinical problem of a growing pelvic tumour
   Acta Oncol, 42 (7), 749-55
   PubMed 14690161
9. Hvamstad T, Jordal A, Hekmat N, Paus E, Fosså SD (2003)
   Neuroendocrine serum tumour markers in hormone-resistant prostate cancer
   Eur Urol, 44 (2), 215-21
   PubMed 12875941
10. Kraggerud SM, Lee MP, Skotheim RI, Stenwig AE, Fosså SD, Feinberg AP, Lothe RA (2003)
    Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumors
    Cancer Genet Cytogenet, 147 (1), 1-8
    PubMed 14580764
11. Lilleby W, Dale E, Olsen DR, Gude U, Fosså SD (2003)
    Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose
    Acta Oncol, 42 (1), 10-4
    PubMed 12665325
12. Lilleby W, Nesland JM, Fosså SD, Torlakovic G, Waehre H, Kvalheim G (2003)
    The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
    Int J Cancer, 103 (1), 91-6
    PubMed 12455058
13. Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fosså SD, Oosterhuis JW (2003)
    Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors
    Cancer Res, 63 (22), 7674-8
    PubMed 14633689
14. Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
    Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
    Eur Urol, 44 (3), 322-8
    PubMed 12932930
15. Nord C, Fossa SD (2003)
    Reply: Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy
    Br. J. Cancer, 89 (6), 1145
16. Nord C, Fosså SD, Egeland T (2003)
    Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
    Br J Cancer, 88 (1), 36-41
    PubMed 12556956
17. Nord C, Mykletun A, Fosså SD (2003)
    Cancer patients' awareness about their diagnosis: a population-based study
    J Public Health Med, 25 (4), 313-7
    PubMed 14747590
18. Norderhaug IN, Sandberg S, Fosså SD, Forland F, Malde K, Kvinnsland S, Traaholt I, Rossiné BK, Førde OH (2003)
    Health technology assessment and implications for clinical practice: the case of prostate cancer screening
    Scand J Clin Lab Invest, 63 (5), 331-8
    PubMed 14599155
19. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD (2003)
    Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses
    J Clin Oncol, 21 (17), 3310-7
    PubMed 12947067
20. Rustøen T, Fosså SD, Skarstein J, Moum T (2003)
    The impact of demographic and disease-specific variables on pain in cancer patients
    J Pain Symptom Manage, 26 (2), 696-704
    PubMed 12906954
21. Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
    Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
    Neoplasia, 5 (5), 397-404
    PubMed 14670177
22. Skotheim RI, Korkmaz KS, Klokk TI, Abeler VM, Korkmaz CG, Nesland JM, Fosså SD, Lothe RA, Saatcioglu F (2003)
    NKX3.1 expression is lost in testicular germ cell tumors
    Am J Pathol, 163 (6), 2149-54
    PubMed 14633588
23. Smeland S, Erikstein B, Aas M, Skovlund E, Hess SL, Fosså SD (2003)
    Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study
    Int J Radiat Oncol Biol Phys, 56 (5), 1397-404
    PubMed 12873686
24. Thorsen L, Nystad W, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
    The level of physical activity in long-term survivors of testicular cancer
    Eur J Cancer, 39 (9), 1216-21
    PubMed 12763208
25. Widmark A, Fosså SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O (2003)
    Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
    Urology, 61 (1), 145-51
    PubMed 12559286

Publications 2002

1. Beyer J, Stenning S, Gerl A, Fossa S, Siegert W (2002)
   High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis
   Ann Oncol, 13 (4), 599-605
   PubMed 12056711
2. Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT (2002)
   Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis
   J Clin Oncol, 20 (7), 1864-73
   PubMed 11919246
3. Curran D, Molenberghs G, Aaronson NK, Fossa SD, Sylvester RJ (2002)
   Analysing longitudinal continuous quality of life data with dropout
   Stat Methods Med Res, 11 (1), 5-23
   PubMed 11923994
4. Fodstad P, Bjøro T, Torlakovic G, Fossa SD (2002)
   No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer
   J Urol, 168 (3), 1188-92
   PubMed 12187265
5. Fossa SD, Collette L, Aaronson N, deWit R, Roberts JT, EORTC GU Group, MRC Testiulcar Cancer Working Part (2002)
   Quality of life in patients with good prognosis metastatic germ cell tumours: Comparison of four chemotherapy schedules (EORTC 30941/MRC TE20)
   GERM CELL TUMOURS V, 183-195
6. Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A (2002)
   Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
   Int J Cancer, 99 (1), 100-5
   PubMed 11948499
7. Fosså SD, Dahl AA (2002)
   Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer
   J Psychosom Res, 52 (2), 79-87
   PubMed 11832253
8. Fosså SD, Skovlund E (2002)
   Selection of patients may limit the generalizability of results from cancer trials
   Acta Oncol, 41 (2), 131-7
   PubMed 12102156
9. Fosså SD, Vaage S, Letocha H, Iversen J, Risberg T, Johannessen DC, Paus E, Smedsrud T, Norwegian Urological Cancer Group (2002)
   Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered
   Scand J Urol Nephrol, 36 (1), 34-9
   PubMed 12002355
10. Fosså SD, Aass N, Winderen M, Börmer OP, Olsen DR (2002)
    Long-term renal function after treatment for malignant germ-cell tumours
    Ann Oncol, 13 (2), 222-8
    PubMed 11885998
11. Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Bokemeyer C (2002)
    Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors
    Ann Oncol, 13 (7), 1017-28
    PubMed 12176779
12. Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
    Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
    Eur Urol, 42 (3), 229-38; discussion 237-8
    PubMed 12234507
13. Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal A, Naylor S, Stenning SP, MRC Testicular Tumour Wor (2002)
    A randomised trial of two radiotherapy schedules in the adjuvant treatment of stage I seminoma (MRC TE18) - Preliminary report
    GERM CELL TUMOURS V, 235-236
14. Kraggerud SM, Aman P, Holm R, Stenwig AE, Fosså SD, Nesland JM, Lothe RA (2002)
    Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis
    Cancer Res, 62 (2), 512-7
    PubMed 11809703
15. Kraggerud SM, Skotheim RI, Szymanska J, Eknaes M, Fosså SD, Stenwig AE, Peltomäki P, Lothe RA (2002)
    Genome profiles of familial/bilateral and sporadic testicular germ cell tumors
    Genes Chromosomes Cancer, 34 (2), 168-74
    PubMed 11979550
16. Kvarstein B, Fosså SD, Harvei S (2002)
    [Diagnosis and treatment of penile cancer]
    Tidsskr Nor Laegeforen, 122 (12), 1194-7
    PubMed 12089846
17. Nesvold IL, Fosså SD (2002)
    [Lymphedema after surgical treatment of cervical and vulvar cancer]
    Tidsskr Nor Laegeforen, 122 (26), 2531-3
    PubMed 12522877
18. Røtterud R, Pettersen EO, Berner A, Holm R, Olsen DR, Fosså SD (2002)
    Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients
    Acta Oncol, 41 (5), 463-70
    PubMed 12442923
19. Skarstein J, Dahl AA, Laading J, Fosså SD (2002)
    'Patient satisfaction' in hospitalized cancer patients
    Acta Oncol, 41 (7-8), 639-45
    PubMed 14651208
20. Skotheim RI, Monni O, Mousses S, Fosså SD, Kallioniemi OP, Lothe RA, Kallioniemi A (2002)
    New insights into testicular germ cell tumorigenesis from gene expression profiling
    Cancer Res, 62 (8), 2359-64
    PubMed 11956097
21. Smith-Sørensen B, Lind GE, Skotheim RI, Fosså SD, Fodstad Ø, Stenwig AE, Jakobsen KS, Lothe RA (2002)
    Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
    Oncogene, 21 (57), 8878-84
    PubMed 12483540
22. Torlakovic E, Lilleby W, Torlakovic G, Fosså SD, Chibbar R (2002)
    Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score
    Hum Pathol, 33 (6), 646-51
    PubMed 12152165
23. Ustün M, Heilo A, Fosså S, Aass N, Berner A (2002)
    Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: diagnosis and therapeutic impact
    Eur Urol, 42 (3), 221-8; discussion 228
    PubMed 12234506
24. Aass N, Fossa SD, Harvei S, Tretli S (2002)
    Mortality rates in patients with malignant germ cell tumours (MGCT) with emphasis on second cancer and cardiovascular mortality
    GERM CELL TUMOURS V, 209-210

Publications 2001

1. Bokemeyer C, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L, Einhorn L, Nichols CR, Hartmann JT (2001)
   Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome
   Cancer, 91 (7), 1394-401
   PubMed 11283942
2. de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, Cook P, de Prijck L, Stenning S, Collette L (2001)
   Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
   J Clin Oncol, 19 (6), 1629-40
   PubMed 11250991
3. Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L, Norwegian Urological Cancer Group (2001)
   No randomised trial of prostate-cancer screening in Norway
   Lancet Oncol, 2 (12), 741-5; discussion 746-9
   PubMed 11902516
4. Fosså SD, Slee PH, Brausi M, Horenblas S, Hall RR, Hetherington JW, Aaronson N, de Prijck L, Collette L (2001)
   Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group
   J Clin Oncol, 19 (1), 62-71
   PubMed 11134196
5. Guren MG, Wiig JN, Dueland S, Tveit KM, Fosså SD, Waehre H, Giercksky KE (2001)
   Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer
   Eur J Surg Oncol, 27 (7), 645-51
   PubMed 11669593
6. Hartmann JT, Einhorn L, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L, Bokemeyer C (2001)
   Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis
   J Clin Oncol, 19 (6), 1641-8
   PubMed 11250992
7. Hartmann JT, Fossa SD, Nichols CR, Droz JP, Horwich A, Gerl A, Beyer J, Pont J, Fizazi K, Hecker H, Kanz L, Einhorn L, Bokemeyer C (2001)
   Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors
   J Natl Cancer Inst, 93 (22), 1733-8
   PubMed 11717334
8. Jacobsen KD, Theodorsen L, Fossa SD (2001)
   Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
   J Urol, 165 (1), 93-6
   PubMed 11125372
9. Lilleby W, Paus E, Skovlund E, Fosså SD (2001)
   Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer
   Prostate, 46 (2), 126-33
   PubMed 11170140
10. Lilleby W, Torlakovic G, Torlakovic E, Skovlund E, Fosså SD (2001)
    Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy
    Cancer, 92 (2), 311-9
    PubMed 11466684
11. Røtterud R, Berner A, Holm R, Skovlund E, Fosså SD (2001)
    p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder
    BJU Int, 88 (3), 202-8
    PubMed 11488730
12. Røtterud R, Skomedal H, Berner A, Danielsen HE, Skovlund E, Fosså SD (2001)
    TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy
    Acta Oncol, 40 (5), 644-52
    PubMed 11669339
13. Skotheim RI, Kraggerud SM, Fosså SD, Stenwig AE, Gedde-Dahl T, Danielsen HE, Jakobsen KS, Lothe RA (2001)
    Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence
    Neoplasia, 3 (3), 196-203
    PubMed 11494113
14. Sternberg CN, de Mulder PH, Schornagel JH, Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van Groeningen CJ, de Balincourt C, Collette L, European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group (2001)
    Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924
    J Clin Oncol, 19 (10), 2638-46
    PubMed 11352955

Publications 2000

1. Barry MJ, Litwin MS, Aaronson NK, Bunyaratavej P, da Silva FC, Fossa SD, Krongrad A, Lobel B, Mebust WK, Trachtenberg JT, Zerbib M (2000)
   Quality of life
   PROSTATE CANCER, 451-479
2. Cappelen T, Fosså SD, Stenwig AE, Aass N (2000)
   False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer
   Acta Oncol, 39 (1), 105-9
   PubMed 10752663
3. Clobes H, Fossâ SD, Waehre H, Jocham D, Berner A (2000)
   The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy
   BJU Int, 85 (3), 270-5
   PubMed 10671880
4. Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, Fossâ SD, Uscinska BM, Parmar MK (2000)
   A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09
   Int J Radiat Oncol Biol Phys, 47 (2), 379-88
   PubMed 10802363
5. Fossâ SD, Skovlund E (2000)
   Interim analyses in clinical trials: why do we plan them?
   J Clin Oncol, 18 (24), 4007-8
   PubMed 11118460
6. Fosså A, Siebert R, Aasheim HC, Maelandsmo GM, Berner A, Fosså SD, Paus E, Smeland EB, Gaudernack G (2000)
   Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
   Br J Cancer, 83 (6), 743-9
   PubMed 10952778
7. Fosså SD (2000)
   Interferon in metastatic renal cell carcinoma
   Semin Oncol, 27 (2), 187-93
   PubMed 10768597
8. Fosså SD, Curran D, Aaronson NK, Keuppens F, Kliment J, Robinson MR, DeReijke TM, Hetherington J, Kil PJ, Rea LA (2000)
   Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893
   Eur Urol, 37 (5), 541-51
   PubMed 10765092
9. Fosså SD, Kravdal O (2000)
   Fertility in Norwegian testicular cancer patients
   Br J Cancer, 82 (3), 737-41
   PubMed 10682691
10. Fosså SD, Aass N, Tveter K, Dahl O (2000)
    [Treatment of renal carcinoma with distant metastases]
    Tidsskr Nor Laegeforen, 120 (19), 2274-8
    PubMed 10997087
11. Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Einhorn L, Kanz L, Bokemeyer C (2000)
    The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
    Cancer, 88 (11), 2629-35
    PubMed 10861442
12. Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Fizazi K, Einhorn L, Kanz L, Bokemeyer C (2000)
    Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors
    J Natl Cancer Inst, 92 (1), 54-61
    PubMed 10620634
13. Hernandez AM, Fosså SD, Brøgger A, Kat A, Skovlund E (2000)
    Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours
    Ann Oncol, 11 (7), 897-8
    PubMed 10997823
14. Hernes EH, Linja M, Fosså SD, Visakorpi T, Berner A, Winderen M, Koivisto PA (2000)
    Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors
    BJU Int, 86 (3), 240-7
    PubMed 10930923
15. Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, Roberts JT, Fossa SD, Dearnaley DP, Lallemand E, Stenning SP, MRC Testicular Tumour Working Party (2000)
    A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
    Br J Cancer, 83 (12), 1623-9
    PubMed 11104556
16. Jacobsen KD, Fosså SD (2000)
    Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle
    Eur Urol, 38 (6), 725-6;discussion 727
    PubMed 11111191
17. Lilleby W, Fosså SD, Knutsen BH, Abildgaard A, Skovlund E, Lien HH (2000)
    Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation
    Radiother Oncol, 57 (2), 195-200
    PubMed 11054523
18. Nord C, Fosså SD, Giercksky KE (2000)
    Gastrointestinal presentation of germ cell malignancy
    Eur Urol, 38 (6), 721-4
    PubMed 11111190
19. Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossâ SD, Tucker K, Donald J, Collins F, Friedlander M, Hogg D, Goss P, Heidenreich A, Ormiston W, Daly PA, Forman D, Oliver TD, Leahy M, Huddart R, Cooper CS, Bodmer JG, Easton DF, Stratton MR, Bishop DT (2000)
    Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
    Nat Genet, 24 (2), 197-200
    PubMed 10655070
20. Rorth M, Meyts ERD, Andersson L, Dieckmann KP, Fossa SD, Grigor KM, Hendry WF, Herr HW, Looijenga LHJ, Oosterhuis JW, Skakkebaek NE (2000)
    Carcinoma in situ in the testis
    Scand. J. Urol. Nephrol., 34 Suppl 205, 166-186
21. Rørth M, Rajpert-De Meyts E, Andersson L, Dieckmann KP, Fosså SD, Grigor KM, Hendry WF, Herr HW, Looijenga LH, Oosterhuis JW, Skakkebaek NE (2000)
    Carcinoma in situ in the testis
    Scand J Urol Nephrol Suppl (205), 166-86
    PubMed 11144894
22. Skarstein J, Aass N, Fosså SD, Skovlund E, Dahl AA (2000)
    Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire
    J Psychosom Res, 49 (1), 27-34
    PubMed 11053601
23. Skovlund E, Fosså SD (2000)
    [PSA analyses in three Norwegian counties in 1999]
    Tidsskr Nor Laegeforen, 120 (21), 2539-41
    PubMed 11070992
24. Steyerberg EW, Keizer HJ, Sleijfer DT, Fossâ SD, Bajorin DF, Gerl A, de Wit R, Kirkels WJ, Koops HS, Habbema JD (2000)
    Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy
    Radiology, 215 (2), 437-44
    PubMed 10796922

Publications 1999

1. Collette L, Sylvester RJ, Stenning SP, Fossa SD, Mead GM, de Wit R, de Mulder PH, Neymark N, Lallemand E, Kaye SB (1999)
   Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party
   J Natl Cancer Inst, 91 (10), 839-46
   PubMed 10340903
2. Dale E, Olsen DR, Fosså SD (1999)
   Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy
   Int J Radiat Oncol Biol Phys, 43 (2), 385-91
   PubMed 10030266
3. Fossa S, Horwich A (1999)
   Is "optimal" radiation for stage I seminoma yet defined? In reply
   J. Clin. Oncol., 17 (9), 3005
4. Fossa SD (1999)
   Good quality of life in prostate cancer patients - How can it be obtained?
   Scand. J. Urol. Nephrol., 33 Suppl 203, 51-52
5. Fosså SD (1999)
   Good quality of life in prostate cancer patients: how can it be obtained?
   Scand J Urol Nephrol Suppl, 203, 51-2
   PubMed 10636571
6. Fosså SD, Bokemeyer C, Gerl A, Culine S, Jones WG, Mead GM, Germa-Luch JR, Pont J, Schmoll HJ, Tjulandin S (1999)
   Treatment outcome of patients with brain metastases from malignant germ cell tumors
   Cancer, 85 (4), 988-97
   PubMed 10091779
7. Fosså SD, Dahl AA, Haaland CF (1999)
   Health-related quality of life in patients treated for testicular cancer
   Curr Opin Urol, 9 (5), 425-9
   PubMed 10579081
8. Fosså SD, Eri LM (1999)
   [Timely screening routines for prostatic cancer by Norwegian physicians]
   Tidsskr Nor Laegeforen, 119 (24), 3572-6
   PubMed 10563174
9. Fosså SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP (1999)
   Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group
   J Clin Oncol, 17 (4), 1146
   PubMed 10561173
10. Fosså SD, Opjordsmoen S, Haug E (1999)
    Androgen replacement and quality of life in patients treated for bilateral testicular cancer
    Eur J Cancer, 35 (8), 1220-5
    PubMed 10615233
11. Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA (1999)
    Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
    Br J Cancer, 80 (9), 1392-9
    PubMed 10424741
12. Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD (1999)
    Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
    Br J Cancer, 80 (1-2), 249-55
    PubMed 10390004
13. Kraggerud SM, Berner A, Bryne M, Pettersen EO, Fossa SD (1999)
    Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study
    APMIS, 107 (3), 297-302
    PubMed 10223302
14. Lilleby W, Fosså SD, Waehre HR, Olsen DR (1999)
    Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
    Int J Radiat Oncol Biol Phys, 43 (4), 735-43
    PubMed 10098428
15. Litwin MS, Fitzpatrick JM, Fossa SD, Newling DW (1999)
    Defining an international research agenda for quality of life in men with prostate cancer
    Prostate, 41 (1), 58-67
    PubMed 10440876
16. Ogreid P, Berner A, Dahl O, Rettedal E, Fosså SD (1999)
    Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy
    Eur Urol, 36 (2), 116-22
    PubMed 10420032
17. Ritchie A, Griffiths G, Parmar M, Fossa SD, Selby PJ, Cornbleet MA, Sibley G, Mead GM, Kaye S, Owen JR, Oliver RTD, Smith PH, Whelan P, Cook PA, Fayers PM, Cook P, Webb J, Whitehead J, Lamont A, Med Res Counc Renal Canc Collaborators (1999)
    Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial
    Lancet, 353 (9146), 14-17
18. Raabe NK, Sauer T, Erichsen A, Nesland JM, Fossaa SD (1999)
    Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer
    Oncol Rep, 6 (5), 1001-7
    PubMed 10425294

Publications 1998

1. Avizienyte E, Roth S, Loukola A, Hemminki A, Lothe RA, Stenwig AE, Fosså SD, Salovaara R, Aaltonen LA (1998)
   Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors
   Cancer Res, 58 (10), 2087-90
   PubMed 9605748
2. Boffetta P, Fichtinger-Schepman AM, Weiderpass E, van Dijk-Knijnenburg HC, Stoter G, van Oosterom AT, Keizer HJ, Fosså SD, Kaldor J, Roy P (1998)
   Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients
   Anticancer Drugs, 9 (2), 125-9
   PubMed 9510497
3. Collette L, Sylvester RJ, Stenning SP, Lallemand E, Fossa SD, Mead GM, de Wit R, de Mulder PHM, Kaye SB, EORTC GU Grp, MRC Testicular Tumour Working Party (1998)
   Does the treating institution have an impact on the overall and failure-free survival of patients with 'poor prognosis' metastatic non-seminomatous germ cell tumours?
   GERM CELL TUMOURS IV, 367-368
4. Dueland S, Stenwig AE, Heilo A, Høie J, Ous S, Fosså SD (1998)
   Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94
   Br J Cancer, 77 (2), 329-35
   PubMed 9461006
5. Fossa SD, Bokemeyer C, Gerl A, Culine S, Jones WG, Mead GM, Germa-Lluch JR, Pont J, Tjulandin S (1998)
   Prognostic factors in patients with brain metastases from malignant germ cell tumours
   GERM CELL TUMOURS IV, 315-325
6. Fossa SD, Horwich A, Russell JM, Roberts JT, Stenning SP, Jakes R, MRC Testicular Working Party (1998)
   Radiotherapy of seminoma stage I: optimal field size. A Medical Research Council (UK) study
   GERM CELL TUMOURS IV, 121-129
7. Fosså SD, Kaye SB, Mead GM, Cullen M, de Wit R, Bodrogi I, van Groeningen CJ, De Mulder PH, Stenning S, Lallemand E, De Prijck L, Collette L (1998)
   Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
   J Clin Oncol, 16 (2), 716-24
   PubMed 9469362
8. Fosså SD, Aass N, Parö G (1998)
   A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma
   Eur J Cancer, 34 (7), 1131-2
   PubMed 9849467
9. Harland SJ, Cook PA, Fossa SD, Horwich A, Mead GM, Parkinson MC, Roberts JT, Stenning SP (1998)
   Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group
   J Urol, 160 (4), 1353-7
   PubMed 9751353
10. Ilner K, Blomlie V, Fosså SD (1998)
    Radiation-induced insufficiency fractures after definitive prostate cancer radiotherapy
    Acta Oncol, 37 (2), 201-2
    PubMed 9636016
11. Jones WG, Stenning SP, Read G, Horwich A, Fossa SD, Oliver RTD, Mead GM, Newlands ES, Cook P (1998)
    Long-term follow-up of unresected residual masses following platinum based chemotherapy for metastatic non-seminoma of the testis (MRC Study TE16): a preliminary report
    GERM CELL TUMOURS IV, 269-275
12. Kaye SB, Mead GM, Fossa S, Cullen M, deWit R, Bodrogi I, van Groeningen C, Sylvester R, Collette L, Stenning S, De Prijck L, Lallemand E, deMulder P (1998)
    Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
    J Clin Oncol, 16 (2), 692-701
    PubMed 9469359
13. Osen I, Fosså SD, Majak B, Røtterud R, Berner A (1998)
    Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study
    Br J Urol, 81 (6), 862-9
    PubMed 9666772
14. Otnes B, Hernes E, Fosså SD (1998)
    [Prostate-specific antigen in the follow-up of conservatively treated prostatic cancer]
    Tidsskr Nor Laegeforen, 118 (22), 3401-5
    PubMed 9800488
15. Paus E, Nilsson O, Børmer OP, Fosså SD, Otnes B, Skovlund E (1998)
    Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia
    J Urol, 159 (5), 1599-605
    PubMed 9554362
16. Rapley E, Tucker K, Collins F, Donald J, Friedlander M, Peng HQ, Goss P, Hogg D, Easton DF, Teare D, Bishop DT, Crockford G, Forman D, Leahy M, Bodmer JG, Moses J, Tonks S, Oliver RTD, Biggs P, Seal S, Barfoot R, Gill S, Patel S, Hamoudi R, Hunter R, Thomlinson I, Cooper C, Stratton M, Huddart R, Fossa SD, Heimdal K, Int Testicular Cancer Linkage Consortium (1998)
    Candidate regions for testicular cancer susceptibility genes
    APMIS, 106 (1), 64-70
17. Raabe NK, Hagen S, Haug E, Fossaa SD (1998)
    Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma
    Int J Oncol, 12 (5), 1091-6
    PubMed 9538134
18. Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM (1998)
    Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
    Cancer, 83 (7), 1409-19
    PubMed 9762943
19. Steyerberg EW, Gerl A, Fossá SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ (1998)
    Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer
    J Clin Oncol, 16 (1), 269-74
    PubMed 9440752
20. Wanderås EH, Grotmol T, Fosså SD, Tretli S (1998)
    Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995
    Cancer Causes Control, 9 (5), 475-86
    PubMed 9934714
21. Aass N, Fosså SD, Dahl AA, Moe TJ (1998)
    [Occurrence of anxiety and depression in cancer patients. An investigation at the Norwegian Radium Hospital]
    Tidsskr Nor Laegeforen, 118 (5), 698-703
    PubMed 9528365

Publications 1997

1. Altwein J, Ekman P, Barry M, Biermann C, Carlsson P, Fosså S, Kiebert G, Küchler T, McLeod D, Porter A, Steineck G (1997)
   How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
   Urology, 49 (4A Suppl), 66-76
   PubMed 9111616
2. Ballico E, Cerichelli G, Fossa S, Floris B, Giordano F (1997)
   Metallation of alkynes .8. Substituent effects in the acetoxymercuration of diarylethynes
   Main Group Met. Chem., 20 (5), 301-312
3. Curran D, Fossa S, Aaronson N, Kiebert G, Keuppens F, Hall R (1997)
   Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)
   Eur J Cancer, 33 (11), 1809-14
   PubMed 9470838
4. de Wit R, Pawinsky A, Stoter G, van Oosterom AT, Fosså SD, Paridaens R, Svedberg A, de Mulder PH (1997)
   EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors
   Eur J Cancer, 33 (3), 493-5
   PubMed 9155537
5. Duchesne GM, Stenning SP, Aass N, Mead GM, Fosså SD, Oliver RT, Horwich A, Read G, Roberts IT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook PA (1997)
   Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party
   Eur J Cancer, 33 (6), 829-35
   PubMed 9291801
6. Fosså SD (1997)
   Residual androgen depending in hormone-resistant prostate cancer
   Acta Oncol, 36 (1), 81-2
   PubMed 9090973
7. Fosså SD, De Angelis P, Kraggerud SM, Evenson D, Theodorsen L, Clausen OP (1997)
   Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin structure assay
   Cytometry, 30 (4), 192-6
   PubMed 9298838
8. Fosså SD, Horwich A (1997)
   Current status of chemotherapy in advanced seminoma
   Eur J Cancer, 33 (2), 181-3
   PubMed 9135484
9. Fosså SD, Oliver RT, Stenning SP, Horwich A, Wilkinson P, Read G, Mead GM, Roberts JT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook P (1997)
   Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
   Eur J Cancer, 33 (9), 1380-7
   PubMed 9337678
10. Fosså SD, Woehre H, Kurth KH, Hetherington J, Bakke H, Rustad DA, Skånvik R (1997)
    Influence of urological morbidity on quality of life in patients with prostate cancer
    Eur Urol, 31 Suppl 3, 3-8
    PubMed 9101208
11. Heimdal K, Olsson H, Tretli S, Fosså SD, Børresen AL, Bishop DT (1997)
    A segregation analysis of testicular cancer based on Norwegian and Swedish families
    Br J Cancer, 75 (7), 1084-7
    PubMed 9083348
12. Herlofson BB, Norman-Pedersen K, Redfors M, Fosså SD (1997)
    Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study
    Eur J Oral Sci, 105 (5 Pt 2), 523-6
    PubMed 9395118
13. Hernes EH, Fosså SD, Vaage S, Ogreid P, Heilo A, Paus E (1997)
    Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study
    Br J Cancer, 76 (1), 93-9
    PubMed 9218739
14. Hollender A, Stenwig EA, Ous S, Fosså SD (1997)
    Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy
    Eur Urol, 31 (2), 141-7
    PubMed 9076455
15. Horwich A, Sleijfer DT, Fosså SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP (1997)
    Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial
    J Clin Oncol, 15 (5), 1844-52
    PubMed 9164194
16. Jacobsen KD, Olsen DR, Fosså K, Fosså SD (1997)
    External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
    Int J Radiat Oncol Biol Phys, 38 (1), 95-102
    PubMed 9212009
17. Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
    A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
    Pathol Res Pract, 193 (7), 471-8
    PubMed 9342752
18. Mead GM, Stenning SP, Cook P, Fossa SD, Horwich A, Kaye SB, Oliver RTD, deMulder PHM, deWit R, Stoter G, Sylvester RJ, Bajorin DF, Bosl GJ, Mazumdar M, Nichols CR, Amato R, Pizzocaro G, Droz JP, Kramar A, Daugaard G, CortesFunes H, PazAres L, Levi JA, Colls BM, Harvey VJ, Coppin C (1997)
    International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
    J. Clin. Oncol., 15 (2), 594-603
19. Newling D, Fosså SD, Andersson L, Abrahamsson PA, Aso Y, Eisenberger MA, Khoury S, Kozlowski JS, Kelly K, Scher H, Hartley-Asp B (1997)
    Assessment of hormone refractory prostate cancer
    Urology, 49 (4A Suppl), 46-53
    PubMed 9111614
20. Pawinski A, van Oosterom AT, de Wit R, Fosså S, Croles J, Svedberg A, Lentz MA, de Mulder PH (1997)
    An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma
    Eur J Cancer, 33 (3), 496-9
    PubMed 9155538
21. Raabe NK, Fosså SD, Kåresen R (1997)
    [Primary invasive breast cancer in Oslo 1980-89. A population based study of 1942 unselected patients treated by radical surgery]
    Tidsskr Nor Laegeforen, 117 (26), 3778-83
    PubMed 9417680
22. Raabe NK, Kaaresen R, Fosså SD (1997)
    Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma--a pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980-1989
    Acta Oncol, 36 (3), 255-60
    PubMed 9208893
23. Raabe NK, Kaaresen R, Fossaa SD (1997)
    Hospital-related differences in breast cancer management. Analysis of an unselected population-based series of 1353 radically operated patients
    Breast Cancer Res Treat, 43 (3), 225-35
    PubMed 9150902
24. Raabe NK, Schistad O, Sauer T, Bofin A, Kaaresen R, Fossaa SD (1997)
    Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area
    APMIS, 105 (5), 363-70
    PubMed 9201237
25. Sternberg CN, de Mulder P, Fossa S, Kaye S, Roberts T, Pawinsky A, Daamen S (1997)
    Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC)
    Ann Oncol, 8 (7), 695-6
    PubMed 9296225
26. Steyerberg EW, Donohue JP, Gerl A, Toner GC, Schraffordt Koops H, Fosså SD, Keizer HJ (1997)
    Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group
    J Urol, 158 (2), 474-8
    PubMed 9224327
27. Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD (1997)
    Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group
    Cancer, 79 (2), 345-55
    PubMed 9010108
28. Tallaksen CM, Jetne V, Fosså S (1997)
    Postradiation lower motor neuron syndrome--a case report and brief literature review
    Acta Oncol, 36 (3), 345-7
    PubMed 9208910
29. Wanderås EH, Fosså SD, Tretli S (1997)
    Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients
    Eur J Cancer, 33 (2), 244-52
    PubMed 9135496
30. Wanderås EH, Fosså SD, Tretli S (1997)
    Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients
    Eur J Cancer, 33 (2), 253-62
    PubMed 9135497
31. Aass N, Fosså SD, Dahl AA, Moe TJ (1997)
    Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital
    Eur J Cancer, 33 (10), 1597-604
    PubMed 9389921
32. Aass N, Håtun DE, Thoresen M, Fosså SD (1997)
    Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients
    Radiother Oncol, 45 (2), 125-8
    PubMed 9424001

Publications 1996

1. Berner A, Skjørten FJ, Fossà SD (1996)
   Follow-up of prostatic intraepithelial neoplasia
   Eur Urol, 30 (2), 256-60
   PubMed 8875208
2. Braendengen M, Winderen M, Fosså SD (1996)
   Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer
   Br J Urol, 77 (1), 36-40
   PubMed 8653315
3. Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, Harland SJ, Williams MV, Jakes R (1996)
   Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report
   J Clin Oncol, 14 (4), 1106-13
   PubMed 8648364
4. da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, Whelan P, Hetherington J, Fava C, Richards B, Robinson MR (1996)
   The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853
   Eur J Cancer, 32A (1), 72-7
   PubMed 8695246
5. Fossa SD, Aass N, Ous S, Waehre H, Ilner K, Hannisdal E (1996)
   Survival after curative treatment of muscle-invasive bladder cancer
   Acta Oncol, 35 Suppl 8, 59-65
   PubMed 9073049
6. Fosså SD (1996)
   Quality of life in prostate cancer: what are the issues and how are they measured?
   Eur Urol, 29 Suppl 2, 121-3
   PubMed 8717474
7. Fosså SD (1996)
   Quality of life in advanced prostate cancer
   Semin Oncol, 23 (6 Suppl 14), 32-4
   PubMed 8996583
8. Fosså SD, Hjermstad MJ, Mørk IH, Hjortdahl P (1996)
   Does the service at a large oncologic out-patient clinic satisfy the patients' perceived need?
   Int J Health Care Qual Assur, 9 (4), 24-9
   PubMed 10159575
9. Fosså SD, Moynihan C, Serbouti S (1996)
   Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study
   Support Care Cancer, 4 (2), 118-28
   PubMed 8673349
10. Fosså SD, Sternberg C, Scher HI, Theodore CH, Mead B, Dearnaley D, Roberts JT, Skovlund E (1996)
    Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
    Br J Cancer, 74 (10), 1655-9
    PubMed 8932351
11. Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD (1996)
    Risk of cancer in relatives of testicular cancer patients
    Br J Cancer, 73 (7), 970-3
    PubMed 8611417
12. Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD (1996)
    Familial testicular cancer in Norway and southern Sweden
    Br J Cancer, 73 (7), 964-9
    PubMed 8611416
13. Loraas A, Fosså SD, Franzen S, Saeter G, Rode L (1996)
    Skin lesions and G-CSF in patients with malignant diseases. Malignancy or cutaneous side-effect?
    Eur J Cancer, 32A (3), 554-5
    PubMed 8814708
14. Otnes B, Harvei S, Fosså SD (1996)
    [Increased incidence of prostatic cancer. The significance of prostate-specific antigen]
    Tidsskr Nor Laegeforen, 116 (15), 1795-9
    PubMed 8693464
15. Raabe NK, Fossaa SD (1996)
    Primary invasive breast carcinoma in Oslo 1980-1989. Incidence and delay
    Acta Oncol, 35 (1), 9-15
    PubMed 8619947
16. Semb KA, Aamdal S, Fosså SD, Oian P (1996)
    Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
    J Exp Ther Oncol, 1 (3), 155-61
    PubMed 9414399
17. Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Bajorin DF, Donohue JP, Habbema JD (1996)
    Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer
    Br J Cancer, 74 (9), 1492-8
    PubMed 8912551

Publications 1995

1. Berner A, Geitvik G, Karlsen F, Fosså SD, Nesland JM, Børresen AL (1995)
   TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue
   J Pathol, 176 (3), 299-308
   PubMed 7674092
2. Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fosså SD (1995)
   DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma
   Br J Urol, 75 (1), 26-32
   PubMed 7531589
3. Brausi M, Jones WG, Fosså SD, de Mulder PH, Droz JP, Lentz MA, van Glabbeke M, Pawinski A (1995)
   High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group
   Eur J Cancer, 31A (10), 1622-6
   PubMed 7488412
4. Davidson PJ, Hop W, Kurth KH, Fossa SD, Waehre H, Schröder FH (1995)
   Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage t0 to 4,N1 to 3.M0,D1). European Organization for Research and Treatment of Cancer Genitourinary Group
   J Urol, 154 (6), 2118-22
   PubMed 7500472
5. Fossa S, Jones M, Johnson P, Joffe J, Holdener E, Elson P, Ritchie A, Selby P (1995)
   Interferon-alpha and survival in renal cell cancer
   Br J Urol, 76 (3), 286-90
   PubMed 7551834
6. Fosså SD (1995)
   [Treatment of testicular cancer in regional health care]
   Tidsskr Nor Laegeforen, 115 (19), 2435-7
   PubMed 7667865
7. Fosså SD (1995)
   [Tumor cells in peripheral blood and bone marrow in patients with prostatic cancer. Many unanswered questions]
   Tidsskr Nor Laegeforen, 115 (29), 3599-600
   PubMed 8539709
8. Fosså SD, Droz JP, Stoter G, Kaye SB, Vermeylen K, Sylvester R (1995)
   Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group
   Br J Cancer, 71 (3), 619-24
   PubMed 7880748
9. Fosså SD, Lehne G, Heimdal K, Theodorsen L (1995)
   Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer
   Oncology, 52 (4), 300-5
   PubMed 7539902
10. Fosså SD, Aamdal S, Naume B, Gallati H (1995)
    Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
    Acta Oncol, 34 (5), 599-603
    PubMed 7546824
11. Gospodarowicz MK, Quilty PM, Scalliet P, Tsujii H, Fossa SD, Horenblas S, Isaka S, Prout GR, Shipley WU, Wijnmaalen AJ (1995)
    The place of radiation therapy as definitive treatment of bladder cancer
    Int J Urol, 2 Suppl 2, 41-8
    PubMed 7553304
12. Heimdal K, Andersen TI, Skrede M, Fosså SD, Berg K, Børresen AL (1995)
    Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population
    Cancer Epidemiol Biomarkers Prev, 4 (2), 123-6
    PubMed 7742719
13. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995)
    Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire
    J Clin Oncol, 13 (5), 1249-54
    PubMed 7738629
14. Ivani G, Fossa S, Jasonni V (1995)
    Anesthesiologist and the child with pain
    Riv. Ital. Pediatr.-Ital. J. Pediatr., 21 (4), 526-528
15. Josefsen D, Waehre H, Paus E, Fosså SD (1995)
    Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancer
    Br J Urol, 75 (4), 502-6
    PubMed 7540482
16. Lothe RA, Peltomäki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM (1995)
    Molecular genetic changes in human male germ cell tumors
    Lab Invest, 73 (5), 606-14
    PubMed 7474934
17. Otnes B, Harvei S, Fosså SD (1995)
    The burden of prostate cancer from diagnosis until death
    Br J Urol, 76 (5), 587-94
    PubMed 8535677
18. Scher HI, Fossa S (1995)
    Prostate cancer in the era of prostate-specific antigen
    Curr Opin Oncol, 7 (3), 281-91
    PubMed 7544627
19. Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Toner GC, Schraffordt Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP (1995)
    Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups
    J Clin Oncol, 13 (5), 1177-87
    PubMed 7537801
20. Wanderås EH, Tretli S, Fosså SD (1995)
    Trends in incidence of testicular cancer in Norway 1955-1992
    Eur J Cancer, 31A (12), 2044-8
    PubMed 8562163

Publications 1994

1. Berner A, Harvei S, Tretli S, Fosså SD, Nesland JM (1994)
   Prostatic carcinoma: a multivariate analysis of prognostic factors
   Br J Cancer, 69 (5), 924-30
   PubMed 7514029
2. Bjerkehagen B, Fosså SD, Raabe N, Holm R, Nesland JM (1994)
   Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV
   Eur Urol, 26 (4), 334-9
   PubMed 7713133
3. de Mulder PH, Sternberg CN, van Oosterom AT, Fossa SD (1994)
   The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract
   Semin Oncol, 21 (1 Suppl 1), 65-9
   PubMed 7512278
4. FOSSA SD (1994)
   TREATMENT OF CEREBRAL METASTASES FROM MALIGNANT GERM-CELL TUMORS
   ADV BIOSCI, 91, 249
5. FOSSA SD (1994)
   QUALITY-OF-LIFE ASSESSMENT IN UNSELECTED ONCOLOGIC OUT-PATIENTS - A PILOT-STUDY
   Int. J. Oncol., 4 (6), 1393-1397
6. FOSSA SD, WANDERAS EH, HEIMDAL K (1994)
   2ND CANCER AFTER TREATMENT OF MALIGNANT GERM-CELL TUMORS
   World J. Urol., 12 (3), 151-154
7. Fosså SD (1994)
   Management of hormone resistant prostate cancer
   Acta Urol Belg, 62 (1), 73-6
   PubMed 7515211
8. Fosså SD (1994)
   Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience
   Br J Urol, 74 (3), 345-51
   PubMed 7524999
9. Fosså SD, Jacobsen AB, Aass N, Heilo A, Stenwig AE, Kummen O, Johannessen NB, Waaler G, Ogreid P, Borge L (1994)
   How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
   Br J Cancer, 70 (6), 1156-60
   PubMed 7981068
10. Fosså SD, Kramar A, Droz JP (1994)
    Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha
    Eur J Cancer, 30A (9), 1310-4
    PubMed 7999419
11. Fosså SD, Paus E (1994)
    Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary report
    Eur Urol, 26 (1), 29-34
    PubMed 7523131
12. Fosså SD, Silde J, Theodorsen L, Pettersen EO (1994)
    Pre-treatment DNA ploidy of sperm cells as a predictive parameter of post-treatment spermatogenesis in patients with testicular cancer
    Br J Urol, 74 (3), 359-65
    PubMed 7953268
13. Fosså SD, Wanderås EH, Heimdal K (1994)
    Second cancer after treatment of malignant germ-cell tumors
    World J Urol, 12 (3), 151-4
    PubMed 7951342
14. Fosså SD, Aass N, Opjordsmoen S (1994)
    Assessment of quality of life in patients with prostate cancer
    Semin Oncol, 21 (5), 657-61
    PubMed 7524156
15. HALL KS, NORDAL KP, BREKKE IB, FOSSA SD (1994)
    PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT WITH BOTH TESTICULAR CANCER AND HEMODIALYSIS-REQUIRING KIDNEY FAILURE
    Int. J. Oncol., 4 (2), 359-362
16. HARLAND SJ, COOK PA, FOSSA SD, HORWICH A, PARKINSON MC, ROBERTS JT, STENNING SP (1994)
    GONADOTROPIN AND SEX-HORMONE LEVELS IN TESTIS CANCER-PATIENTS WITH AND WITHOUT CARCINOMA IN-SITU OF THE CONTRALATERAL TESTIS
    ADV BIOSCI, 91, 73-76
17. Heimdal K, Fosså SD (1994)
    Genetic factors in malignant germ-cell tumors
    World J Urol, 12 (4), 178-81
    PubMed 7820137
18. HEIMDAL K, LOTHE RA, FOSSA SD, BORRESEN AL (1994)
    THE WILMS-TUMOR 1 GENE IN TESTICULAR CANCER-PATIENTS
    ADV BIOSCI, 91, 145-146
19. Heimdal KR, Lothe RA, Fosså SD, Børresen AL (1994)
    Association studies of a polymorphism in the Wilms' tumor 1 locus in Norwegian patients with testicular cancer
    Int J Cancer, 58 (4), 523-6
    PubMed 8056449
20. Haarstad H, Jacobsen AB, Schjølseth SA, Risberg T, Fosså SD (1994)
    Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study
    Ann Oncol, 5 (3), 245-8
    PubMed 8186172
21. Jacobsen KD, Follerås G, Fosså SD (1994)
    Metastases from renal cell carcinoma to the humerus or the shoulder girdle
    Br J Urol, 73 (2), 124-8
    PubMed 8131012
22. MASSONE ML, CAMA A, PUCCIO VF, MONTOBBIO G, SOLIANI M, ANDREUSSI L, FOSSA S (1994)
    EARLY TREATMENT OF POSTHEMORRHAGIC VENTRICULAR DILATATION OF THE NEWBORN WITH LONG-TERM EXTERNAL VENTRICULAR DRAINAGE
    J. Perinat. Med., 22 Suppl 1, 185
23. Møller P, Fosså SD, Heimdal K, Kvinnsland S, Giercksky KE, Woehre H (1994)
    [Screening for early diagnosis of prostatic cancer]
    Tidsskr Nor Laegeforen, 114 (9), 1104-5
    PubMed 8009529
24. Opjordsmoen S, Fosså SD (1994)
    Quality of life in patients treated for penile cancer. A follow-up study
    Br J Urol, 74 (5), 652-7
    PubMed 7827818
25. Opjordsmoen S, Waehre H, Aass N, Fossa SD (1994)
    Sexuality in patients treated for penile cancer: patients' experience and doctors' judgement
    Br J Urol, 73 (5), 554-60
    PubMed 8012779
26. STEYERBERG EW, KEIZER HJ, FOSSA SD, MULDERS PFA, STOTER G, MESSEMER JE, NEY K, DONOHUE JP, TONER GC, BAJORIN D, BOSL GJ, HABBEMA JDF (1994)
    PREDICTORS OF RESIDUAL MASS HISTOLOGY FOLLOWING CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GCT - UNIVARIATE AND MULTIVARIATE METAANALYSIS
    ADV BIOSCI, 91, 239-240
27. WANDERAS EH, FOSSA SD, TRETLI S, KLEPP O (1994)
    TOXICITY IN LONG-TERM SURVIVORS AFTER ADRIAMYCIN CONTAINING CHEMOTHERAPY OF MALIGNANT GERM-CELL TUMORS
    Int. J. Oncol., 4 (3), 681-688
28. Yao WQ, Fosså SD, Dearnaley DP, Horwich A (1994)
    Combined single course carboplatin with radiotherapy in treatment of stage IIA,B seminoma--a preliminary report
    Radiother Oncol, 33 (1), 88-90
    PubMed 7878216
29. AASS N, FOSSA SD (1994)
    LATE SIDE-EFFECTS IN PATIENTS TREATED FOR TESTICULAR CANCER
    ADV BIOSCI, 91, 337-343
30. Aass N, Fosså SD (1994)
    Aims and results of palliative radiotherapy in urological cancer
    Curr Opin Oncol, 6 (3), 308-12
    PubMed 7521671

Publications 1993

1. Berner A, Danielsen HE, Juul NO, Juul ME, Pettersen EO, Reith A, Nesland JM, Fosså SD (1993)
   Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry
   Anal Cell Pathol, 5 (6), 339-52
   PubMed 8305330
2. Berner A, Danielsen HE, Pettersen EO, Fosså SD, Reith A, Nesland JM (1993)
   DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas
   Anal Quant Cytol Histol, 15 (4), 247-52
   PubMed 7691062
3. Berner A, Jacobsen AB, Fosså SD, Nesland JM (1993)
   Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder
   Histopathology, 22 (4), 327-33
   PubMed 8099896
4. Berner A, Nesland JM, Waehre H, Silde J, Fosså SD (1993)
   Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens
   Br J Cancer, 68 (2), 380-4
   PubMed 7688548
5. Blomlie V, Lehne G, Lien HH, Winderen M, Fosså SD (1993)
   Meningeal tumour infiltration in hormone resistant prostate cancer demonstrated with magnetic resonance
   Eur J Cancer, 29A (9), 1357
   PubMed 8343288
6. FOSSA SD, GUNDERSON R, LEHNE G, HJELMAAS U (1993)
   TREATMENT OF METASTATIC RENAL-CELL CARCINOMA WITH HIGH-DOSE INTERFERON AND PREDNISONE
   RENAL CELL CARCINOMA - IMMUNOTHERAPY AND CELLULAR BIOLOGY , 297-303
7. Fosså SD, Aune H, Baggerud E, Granerud T, Heilo A, Theodorsen L (1993)
   Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma
   Eur J Cancer, 29A (9), 1313-5
   PubMed 8343275
8. Fosså SD, Berner AA, Jacobsen AB, Waehre H, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Silde J, Nesland JM (1993)
   Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer
   Br J Cancer, 68 (3), 572-8
   PubMed 8102536
9. Fosså SD, Heilo A, Sövik E (1993)
   Quality control of computed tomograms in testicular tumours
   Lancet, 341 (8861), 1666
   PubMed 8100034
10. Fosså SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993)
    Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
    Cancer, 72 (10), 3036-43
    PubMed 8221571
11. Fosså SD, Winderen M (1993)
    Does decreased skeletal uptake of 99mTc-methylene bisphosphonate in irradiated bone indicate the absence of bone metastases?
    Radiother Oncol, 27 (1), 63-5
    PubMed 8327735
12. Fosså SD, Aabyholm T, Vespestad S, Norman N, Ous S (1993)
    Semen quality after treatment for testicular cancer
    Eur Urol, 23 (1), 172-6
    PubMed 8477777
13. Hannisdal E, Fosså SD, Høst H (1993)
    Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy
    Radiother Oncol, 27 (2), 117-22
    PubMed 8356221
14. Harland SJ, Cook PA, Fosså SD, Horwich A, Parkinson MC, Roberts JT, Stenning SP (1993)
    Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report
    Eur Urol, 23 (1), 115-8; discussion 119
    PubMed 8477771
15. Heikkilä R, Heilo A, Stenwig AE, Fosså SD (1993)
    Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours
    Br J Urol, 71 (2), 214-6
    PubMed 8384915
16. Heimdal K, Fosså SD (1993)
    Urologic cancer in elderly patients
    Curr Opin Oncol, 5 (3), 568-73
    PubMed 8494916
17. Heimdal K, Lothe RA, Lystad S, Holm R, Fosså SD, Børresen AL (1993)
    No germline TP53 mutations detected in familial and bilateral testicular cancer
    Genes Chromosomes Cancer, 6 (2), 92-7
    PubMed 7680893
18. Josefsen D, Ous S, Høie J, Stenwig AE, Fosså SD (1993)
    Salvage treatment in male patients with germ cell tumours
    Br J Cancer, 67 (3), 568-72
    PubMed 8382512
19. Kelly WK, Scher HI, Mazumdar M, Vlamis V, Schwartz M, Fossa SD (1993)
    Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer
    J Clin Oncol, 11 (4), 607-15
    PubMed 7683043
20. Lehne G, Johansen B, Fosså SD (1993)
    Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin
    Br J Cancer, 68 (3), 555-8
    PubMed 7688978
21. Lothe RA, Hastie N, Heimdal K, Fosså SD, Stenwig AE, Børresen AL (1993)
    Frequent loss of 11p13 and 11p15 loci in male germ cell tumours
    Genes Chromosomes Cancer, 7 (2), 96-101
    PubMed 7687459
22. Newling DW, Fossa SD, Tunn UW, Kurth KH, de Pauw M, Sylvester R (1993)
    Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)
    J Urol, 150 (6), 1840-4
    PubMed 8230517
23. OTTESDAD L, PETTERSEN EO, NESLAND JM, HANNISDAL E, FOSSA SD, TVEIT KM (1993)
    FLOW CYTOMETRIC DNA ANALYSIS AS PROGNOSTIC FACTOR IN HUMAN BREAST-CARCINOMA
    Pathol. Res. Pract., 189 (4), 405-410
24. Ottestad L, Pettersen EO, Nesland JM, Hannisdal E, Fosså SD, Tveit KM (1993)
    Flow cytometric DNA analysis as prognostic factor in human breast carcinoma
    Pathol Res Pract, 189 (4), 405-10
    PubMed 8351241
25. Ridanpää M, Lothe RA, Onfelt A, Fosså S, Børresen AL, Husgafvel-Pursiainen K (1993)
    K-ras oncogene codon 12 point mutations in testicular cancer
    Environ Health Perspect, 101 Suppl 3, 185-7
    PubMed 8143614
26. Rintala E, Hannisdahl E, Fosså SD, Hellsten S, Sander S (1993)
    Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I
    Scand J Urol Nephrol, 27 (3), 355-62
    PubMed 8290916
27. Ryberg D, Heimdal K, Fosså SD, Børresen AL, Haugen A (1993)
    Rare Ha-ras1 alleles and predisposition to testicular cancer
    Int J Cancer, 53 (6), 938-40
    PubMed 8097187
28. Räth U, Upadhyaya BK, Arechavala E, Böckmann H, Dearnaley D, Droz JP, Fosså SD, Henriksson R, Aulitzky WE, Jones WG (1993)
    Role of ondansetron plus dexamethasone in fractionated chemotherapy
    Oncology, 50 (3), 168-72
    PubMed 8459987
29. Sternberg CN, de Mulder PH, van Oosterom AT, Fossa SD, Giannarelli D, Soedirman JR (1993)
    Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors
    Ann Oncol, 4 (5), 403-7
    PubMed 8353075
30. van den Ouden D, Tribukait B, Blom JH, Fossa SD, Kurth KH, ten Kate FJ, Heiden T, Wang N, Schroder FH (1993)
    Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group
    J Urol, 150 (2 Pt 1), 400-6
    PubMed 8326563
31. Waehre H, Ous S, Klevmark B, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Fosså SD (1993)
    A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer
    Cancer, 72 (10), 3044-51
    PubMed 8221572
32. WOEHRE H, OUS S, KLEVMARK B, KVARSTEIN B, URNES T, OGREID P, JOHANSEN TEB, FOSSA SD (1993)
    A BLADDER-CANCER MULTIINSTITUTIONAL EXPERIENCE WITH TOTAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER-CANCER
    Cancer, 72 (10), 3044-3051
33. Aaserud A, Thomle S, Fosså SD (1993)
    [Treatment of threatened spinal cord lesions in patients with prostatic cancer]
    Tidsskr Nor Laegeforen, 113 (17), 2141
    PubMed 8337680
34. AASS N, GRUNFELD B, KAALHUS O, FOSSA SD (1993)
    PRETREATMENT AND POSTTREATMENT SEXUAL LIFE IN TESTICULAR CANCER-PATIENTS - A DESCRIPTIVE INVESTIGATION
    Br. J. Cancer, 67 (5), 1113-1117
35. Aass N, Grünfeld B, Kaalhus O, Fosså SD (1993)
    Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation
    Br J Cancer, 67 (5), 1113-7
    PubMed 8494708

Publications 1992

1. Clavel M, Monfardini S, Fosså S, Smyth J, Renard J, Kaye SB (1992)
   5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary Group
   Ann Oncol, 3 (5), 399-400
   PubMed 1377488
2. DENIS L, PEELING WB, NARAYAN P, COONER WH, HENRIKX AJM, POLLACK HM, DEMOURA JC, FOSSA S, TORPPEDERSEN S (1992)
   PROSTATE-CANCER - IMAGING, MANAGEMENT, AND SCREENING - PROCEEDINGS OF THE PROSTATE SESSIONS AT THE 1ST INTERNATIONAL-CONGRESS OF THE DUTCH-UROLOGICAL-ASSOCIATION (NVU) HELD IN ROTTERDAM, THE NETHERLANDS OCTOBER 9-13, 1991 - ROUND-TABLE DISCUSSION
   Prostate (Suppl 4), 59-62
3. FOSSA SD, DEARNALEY DP (1992)
   PROSTATE SPECIFIC ANTIGEN VALUES AFTER RADICAL RETROPUBIC PROSTATECTOMY FOR ADENOCARCINOMA OF THE PROSTATE - IMPACT OF ADJUVANT TREATMENT (HORMONAL AND RADIATION)
   J. Urol., 147 (1), 173-174
4. FOSSA SD, KAASA S, DASILVA FC, SUCIU S, HENGEVELD MW (1992)
   QUALITY-OF-LIFE IN PROSTATE-CANCER PATIENTS
   Prostate (Suppl 4), 145-148
5. Fossa SD, Mason M (1992)
   Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer
   Br J Urol, 69 (1), 108
   PubMed 1371085
6. FOSSA SD, PAUS E, LOCHOFF M, BACKE SM, AAS M (1992)
   SR-89 IN BONE METASTASES FROM HORMONE RESISTANT PROSTATE-CANCER - PALLIATION EFFECT AND BIOCHEMICAL-CHANGES
   Br. J. Cancer, 66 (1), 177-180
7. Fosså S (1992)
   Rare and unusual tumors of the genitourinary tract
   Curr Opin Oncol, 4 (3), 463-8
   PubMed 1323334
8. Fosså SD, Berner A, Waehre H, Heiden T, Juul ME, van den Ouden D, Pettersen EO, Wang N, Tribukait B (1992)
   DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories
   Cytometry, 13 (4), 395-403
   PubMed 1526198
9. Fosså SD, Dearnaley DP, Law M, Gad J, Newling DW, Tveter K (1992)
   Prognostic factors in hormone-resistant progressing cancer of the prostate
   Ann Oncol, 3 (5), 361-6
   PubMed 1616889
10. Fosså SD, Droz JP, Pavone-Macaluso MM, Debruyne FJ, Vermeylen K, Sylvester R (1992)
    Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group
    Eur J Cancer, 28A (4-5), 878-80
    PubMed 1524914
11. Fosså SD, Harland SJ, Kaye SB, Raghavan D, Russell JM, Parmar MK, Uscinska BM, Wood R (1992)
    Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)
    Br J Urol, 70 (2), 161-8
    PubMed 1393439
12. Fosså SD, Klepp O, Paus E (1992)
    Neuron-specific enolase--a serum tumour marker in seminoma?
    Br J Cancer, 65 (2), 297-9
    PubMed 1739633
13. Fosså SD, Kaasa S, da Silva FC, Suciu S, Hengeveld MW (1992)
    Quality of life in prostate cancer patients
    Prostate Suppl, 4, 145-8
    PubMed 1574455
14. Fosså SD, Lehne G, Gunderson R, Hjelmaas U, Holdener EE (1992)
    Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies
    Int J Cancer, 50 (6), 868-70
    PubMed 1372881
15. Fosså SD, Martinelli G, Otto U, Schneider G, Wander H, Oberling F, Bauer HW, Achtnicht U, Holdener EE (1992)
    Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study
    Ann Oncol, 3 (4), 301-5
    PubMed 1390305
16. Fosså SD, Ous S, Espetveit S, Langmark F (1992)
    Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer
    Scand J Urol Nephrol, 26 (2), 131-8
    PubMed 1626202
17. Fosså SD, Paus E, Lindegaard M, Newling DW (1992)
    Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment
    Br J Urol, 69 (2), 175-9
    PubMed 1371425
18. Fosså SD, Paus E, Lochoff M, Backe SM, Aas M (1992)
    89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes
    Br J Cancer, 66 (1), 177-80
    PubMed 1379058
19. Fosså SD, Poulsen JP, Aaserud A (1992)
    Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer
    Lancet, 340 (8834-8835), 1544
    PubMed 1281904
20. Fosså SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE (1992)
    Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    J Clin Oncol, 10 (4), 569-73
    PubMed 1312586
21. Fosså SD, Waehre H, Paus E (1992)
    The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer
    Br J Cancer, 66 (1), 181-4
    PubMed 1379059